← SynDRA
AV-412 FREE BASE
SynDRA canonical compound SYN0033794 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ERBB2 |
|---|
| Mechanism of action | Receptor tyrosine protein kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Receptor tyrosine protein kinase inhibitor
- EGFR INHIBITOR
- Epidermal growth factor receptor erbB1 inhibitor
- ERBB2 INHIBITOR
- Receptor protein-tyrosine kinase erbB-2 inhibitor
- tyrosine kinase inhibitor
Cross-references
Synonyms
- AV-412
- UNII-41OXH4FE7B
- MP-312
- RefChem:115727
- DTXCID80118894
- MP 412
- AV-412 (free base)
- MFCD16038939
- AV-412(MP-412)
- C27H28ClFN6O
- HMS3244M15
- MP-412 free base
- orb1678998
- SCHEMBL1818495
- SCHEMBL29479075
- SCHEMBL29944737
- AV-412 free base;MP-412
- EX-A755
- GLXC-07053
- HMS3244M16
- HMS3244N15
- BDBM50468245
- HY-10346A
- NSC799340
- TQ0293
- AKOS027251058
- NSC-799340
- NCGC00263195-01
- NCGC00263195-03
- NCGC00263195-04
- AC-36037
- AS-16187
- NS00071666
- BRD-K23190681-001-01-1
- T10419
- AKOS027338673
- AV-412 bis-tisylate
Look up AV-412 FREE BASE in the interactive SynDRA portal →